| |
Quartile
| | | | |
|---|
|
Variable
|
1 (Lowest) (n = 436)
|
2 (n = 436)
|
3 (n = 436)
|
4 (Highest) (n = 437)
|
P for trend
|
|---|
|
Total fat
|
|
Intake, g/day*
|
47.2
|
54.7
|
60.4
|
69.7
| |
|
Prevalence, %†
|
23.9
|
25.2
|
25.7
|
28.8
| |
|
Crude OR (95% CI)
|
1.00
|
1.08 (0.79-1.47)
|
1.10 (0.81-1.50)
|
1.29 (0.96-1.75)
|
0.10
|
|
Adjusted OR (95% CI)‡
|
1.00
|
1.09 (0.79-1.49)
|
1.11 (0.81-1.53)
|
1.31 (0.96-1.79)
|
0.09
|
|
Saturated fatty acids
|
|
Intake, g/day*
|
12.6
|
15.5
|
17.6
|
21.2
| |
|
Prevalence, %†
|
25.7
|
25.2
|
23.6
|
29.1
| |
|
Crude OR (95% CI)
|
1.00
|
0.98 (0.72-1.32)
|
0.90 (0.66-1.22)
|
1.19 (0.88-1.60)
|
0.36
|
|
Adjusted OR (95% CI)‡
|
1.00
|
0.99 (0.72-1.35)
|
0.96 (0.70-1.32)
|
1.20 (0.88-1.63)
|
0.29
|
|
Monounsaturated fatty acids
|
|
Intake, g/day*
|
15.7
|
18.9
|
21.2
|
25.0
| |
|
Prevalence, %†
|
24.3
|
25.0
|
25.9
|
28.4
| |
|
Crude OR (95% CI)
|
1.00
|
1.04 (0.76-1.41)
|
1.09 (0.80-1.48)
|
1.23 (0.91-1.67)
|
0.16
|
|
Adjusted OR (95% CI)‡
|
1.00
|
0.99 (0.72-1.36)
|
1.08 (0.79-1.48)
|
1.19 (0.87-1.63)
|
0.21
|
|
n-3 Polyunsaturated fatty acids
|
|
Intake, g/day*
|
1.7
|
2.1
|
2.4
|
2.9
| |
|
Prevalence, %†
|
25.5
|
25.2
|
24.8
|
28.2
| |
|
Crude OR (95% CI)
|
1.00
|
0.99 (0.73-1.34)
|
0.96 (0.71-1.31)
|
1.15 (0.85-1.55)
|
0.42
|
|
Adjusted OR (95% CI)‡
|
1.00
|
0.92 (0.67-1.26)
|
0.90 (0.65-1.23)
|
1.07 (0.78-1.45)
|
0.72
|
|
α-Linolenic acid
|
|
Intake, g/day*
|
1.2
|
1.5
|
1.8
|
2.2
| |
|
Prevalence, %†
|
25.0
|
23.2
|
28.2
|
27.2
| |
|
Crude OR (95% CI)
|
1.00
|
0.90 (0.66-1.23)
|
1.18 (0.87-1.59)
|
1.12 (0.83-1.52)
|
0.21
|
|
Adjusted OR (95% CI)‡
|
1.00
|
0.88 (0.64-1.21)
|
1.18 (0.86-1.60)
|
1.04 (0.76-1.42)
|
0.43
|
|
Eicosapentaenoic acid
|
|
Intake, g/day*
|
0.07
|
0.12
|
0.17
|
0.29
| |
|
Prevalence, %†
|
25.7
|
25.2
|
27.1
|
25.6
| |
|
Crude OR (95% CI)
|
1.00
|
0.98 (0.72-1.32)
|
1.07 (0.79-1.45)
|
1.00 (0.74-1.35)
|
0.86
|
|
Adjusted OR (95% CI)‡
|
1.00
|
0.91 (0.67-1.25)
|
1.00 (0.73-1.37)
|
0.93 (0.68-1.28)
|
0.81
|
|
Docosahexaenoic acid
|
|
Intake, g/day*
|
0.14
|
0.22
|
0.30
|
0.46
| |
|
Prevalence, %†
|
25.2
|
25.2
|
29.4
|
23.8
| |
|
Crude OR (95% CI)
|
1.00
|
1.00 (0.74-1.36)
|
1.23 (0.91-1.66)
|
0.93 (0.68-1.26)
|
0.98
|
|
Adjusted OR (95% CI)‡
|
1.00
|
0.93 (0.68-1.27)
|
1.13 (0.83-1.54)
|
0.88 (0.64-1.21)
|
0.73
|
|
n-6 Polyunsaturated fatty acids
|
|
Intake, g/day*
|
8.5
|
10.2
|
11.5
|
13.5
| |
|
Prevalence, %†
|
24.3
|
23.2
|
30.1
|
26.1
| |
|
Crude OR (95% CI)
|
1.00
|
0.94 (0.69-1.28)
|
1.34 (0.99-1.81)
|
1.10 (0.81-1.49)
|
0.19
|
|
Adjusted OR (95% CI)‡
|
1.00
|
0.91 (0.66-1.26)
|
1.34 (0.98-1.83)
|
1.05 (0.77-1.45)
|
0.29
|
|
Linoleic acid
|
|
Intake, g/day*
|
8.3
|
10.0
|
11.3
|
13.1
| |
|
Prevalence, %†
|
24.3
|
23.6
|
29.1
|
26.5
| |
|
Crude OR (95% CI)
|
1.00
|
0.96 (0.71-1.31)
|
1.28 (0.95-1.73)
|
1.13 (0.83-1.53)
|
0.19
|
|
Adjusted OR (95% CI)‡
|
1.00
|
0.94 (0.68-1.29)
|
1.27 (0.93-1.73)
|
1.08 (0.79-1.48)
|
0.30
|
|
Arachidonic acid
|
|
Intake, g/day*
|
0.09
|
0.12
|
0.14
|
0.18
| |
|
Prevalence, %†
|
25.0
|
24.1
|
28.4
|
26.1
| |
|
Crude OR (95% CI)
|
1.00
|
0.95 (0.70-1.30)
|
1.19 (0.88-1.61)
|
1.06 (0.78-1.44)
|
0.42
|
|
Adjusted OR (95% CI)‡
|
1.00
|
0.90 (0.65-1.23)
|
1.20 (0.88-1.63)
|
1.05 (0.77-1.43)
|
0.39
|
|
n-3/n-6 Polyunsaturated fatty acid ratio
|
|
Intake*
|
0.17
|
0.19
|
0.21
|
0.25
| |
|
Prevalence, %†
|
24.8
|
26.8
|
27.8
|
24.3
| |
|
Crude OR (95% CI)
|
1.00
|
1.11 (0.82-1.51)
|
1.17 (0.86-1.58)
|
0.97 (0.71-1.32)
|
0.95
|
|
Adjusted OR (95% CI)‡
|
1.00
|
1.07 (0.78-1.46)
|
1.07 (0.78-1.46)
|
0.92 (0.67-1.26)
|
0.61
|
|
Cholesterol
| | | | | |
|
Intake, mg/day*
|
182.0
|
244.5
|
308.0
|
402.7
| |
|
Prevalence, %†
|
26.4
|
22.5
|
28.0
|
26.8
| |
|
Crude OR (95% CI)
|
1.00
|
0.81 (0.59-1.10)
|
1.09 (0.81-1.46)
|
1.02 (0.76-1.38)
|
0.48
|
|
Adjusted OR (95% CI)‡
|
1.00
|
0.82 (0.60-1.13)
|
1.10 (0.81-1.49)
|
1.05 (0.77-1.42)
|
0.41
|
- * Values for intake are medians for adjusted energy intake using the residual method for each quartile.
-
† Prevalence of rhinoconjunctivitis based on the International Study of Asthma and Allergies in Childhood for each quartile.
-
‡ Adjustment for age; gestation; region of residence; number of older siblings; number of children; smoking; secondhand smoke exposure at home and at work; family history of asthma, atopic eczema, and allergic rhinitis; household income; education; and body mass index.
